Navigation Links
Validus Pharmaceuticals Now Exclusively Marketing Six Established U.S. Product Lines Purchased From Leading Healthcare Company
Date:11/19/2012

out the potential for our strategy."

As manufacturing of these products transitions to Validus, the company is working rapidly in order to assure both physicians and patients of a continued product supply under their label. Validus will be communicating directly with distributors and prescribing physicians regarding the availability of all these products.

About Validus Pharmaceuticals
Validus Pharmaceuticals LLC is a Parsippany, New Jersey-based specialty pharmaceutical company focused on the acquisition, reformulation, and marketing of FDA-approved prescription products that satisfy unmet clinical needs.  To fulfill this mission, Validus seeks out and acquires marketed products that have well established safety profiles as well as significant clinical benefits. 

For additional information please visit www.validuspharma.com.

About Wood Creek Capital Management, LLC

Wood Creek Capital Management is an investment manager at the forefront of private assets investing.  Headquartered in New Haven, CT Wood Creek has $930 million of committed capital under management as of June 30, 2012.  Wood Creek is a leading investor in intangible assets including pharmaceutical brands. 

For additional information please visit www.woodcreekcap.com.


'/>"/>
SOURCE Validus Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013  Cataracts are the leading cause of ... of Ophthalmology, aging is the leading cause of eye ... natural lens. 22 million Americans age 40 and older ... to age, that number will increase over 30 million. ... iPads, smart-phones and computers, the demographic of ages 40 ...
(Date:6/18/2013)... , June 18, 2013  In a letter to ... , M.D., of Lake View, Iowa , ... receive annual influenza vaccine is neither scientifically justified nor ethically ... article in the summer issue of the Journal ... official statistics are correct, and an average of 36,000 patients ...
(Date:6/18/2013)... 2013 Decision Resources, one of the world,s leading ... that, over the past 12 months, 25 percent of surveyed ... Germany , Italy , ... ) have been required to change the antiretroviral (ARV) ... to reduce costs. Additionally, more than 40 percent of respondents ...
Breaking Medicine Technology:New Vision Hope For Millions Undergoing Cataract Surgery 2New Vision Hope For Millions Undergoing Cataract Surgery 3Mandated Flu Vaccine for Hospital Workers Ethically Questionable, Surgeon Writes 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3
... , PITTSBURGH, Dec. 11 Mylan Inc. (Nasdaq: ... Inc. received final approval from the U.S. Food and ... (ANDA) for Levetiracetam Tablets, 1000 mg. Levetiracetam Tablets are ... additional strength of Levetiracetam Tablets complements Mylan,s already approved ...
... OXFORD, England, December 11 , ... T-cell Vaccine , - Funding to ... Circassia Ltd, a specialty biopharmaceutical company focused on ... million),fundraising. The investment round, which was led by Imperial Innovations ...
Cached Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2
(Date:6/18/2013)... cancer cells have a much different and more ... The University of Texas at Dallas have found that ... combat lung cancer. , In an article published online ... UT Dallas researchers compared the metabolic characteristics of non-small-cell ... the same patient. , They found that the ...
(Date:6/18/2013)... and mapped the signaling network between two previously unconnected ... off cancer cell growth at its starting point. , ... Texas MD Anderson Cancer Center reported the tie between ... target, and MCM7, a protein vital to the first ... Cancer Cell . , "MCM7 overexpression marks cell ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The Elizabeth ... of State and the U.S. President’s Emergency Plan for ... and celebrate significant new milestones in the global effort ... John Kerry announced that as of June 2013, one ... PEPFAR support. Since PEPFAR’s inception in 2003, EGPAF ...
(Date:6/18/2013)... Healthcare Solutions , the parent ... today announced the appointment of Richard Leonardo to ... position, Leonardo will direct Healthcare Solutions’ national sales ... initiatives. , Recognized in the property and casualty ... more than 20 years of experience in business ...
(Date:6/18/2013)... As Mirena lawsuit claims continue ... new report has revealed that that the IUD has been ... Administration (FDA) adverse event reports since coming on the market ... 4.700 Mirena users have reported device dislocation or migration to ... experienced uterine perforations due to Mirena.* , “We are not ...
Breaking Medicine News(10 mins):Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3
... the microbiological equilibrium in the female genital tract can ... the Deutsches rzteblatt International ( Dtsch Arztebl ... Eva-Maria Bitzer investigates a method of screening for such ... and preterm deliveries. To avoid these, in a model ...
... York Academy of Sciences, "Vaccines Under the Gun: Politics, Science, ... J. Thomasch, JD, national lead trial counsel for Wyeth, who ... yesterday in which the justices rejected a lawsuit claiming injury ... was brought by the parents of a child who has ...
... Children,s Hospital of Orange County (CHOC Children,s) today announced it ... gift in the hospital,s history. This transformational gift ... donor,s intent by using the funds to support the $125 ... make Orange County, Calif., one of the safest and healthiest ...
... receptor diversity in blood samples from healthy individuals has been ... online today in Genome Research ( www.genome.org ), ... cancer, and immune system disorders. Adaptive immunity is mediated ... cells that may be infected with viruses or contain cancer-causing ...
... -- Researchers say they,ve developed a new and potentially ... technology. The laser equipment spots key differences in ... explained. As currently envisioned, the new screening procedure ... as a tissue biopsy) before the laser-imaging diagnosis could ...
... A team of neuroscientists at Cold Spring Harbor Laboratory (CSHL), ... collected evidence suggesting that a previously overlooked portion of the ... In two rat models of human depression, the ... the central brain called the lateral habenula (LHb) are hyperactive. ...
Cached Medicine News:Health News:Experts explore vaccines: Science, legal, social issues at New York Academy of Sciences 2Health News:Children's Hospital of Orange County receives largest gift in hospital history 2Health News:Entire T-cell receptor repertoire sequenced revealing extensive and unshared diversity 2Health News:Laser Technology Might Help Doctors Diagnose Melanoma 2Health News:Neuroscientists find overlooked brain area is an important locus of depression 2Health News:Neuroscientists find overlooked brain area is an important locus of depression 3
... The herbal extracts, vitamins, ... formula increases circulation to ocular ... maintains healthy function of the ... eye. This formula is optimized ...
... industry-leading portal to QC information, providing laboratory ... to access their quality control data and ... UnityWeb enables Bio-Rad customers to access on-demand ... well as convenient online data entry and ...
The ACCU-CHEK Spirit insulin pump system offers frequent and precise delivery of the basal rate and rapid infusion of the bolus. The ACCU-CHEK Spirit pump is safe, reliable and easy to program....
The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie...
Medicine Products: